Home›Companies›Biotech & Pharma›Therini Bio

Therini Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 8, 2025·Suggest an edit

About Therini Bio

Therini Bio is a private company based in Sacramento, California. It has reported $84,226,899 raised in two offerings on Form D since May 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 29, 2023Apr 14, 2023amended Sep 8, 2025$74,870,150of $80.7M target17$4.4MEquity, DebtRule 506(b)Form D/A ↗1 earlier filing
May 8, 2019May 17, 2019amended May 22, 2020$9,356,749fully sold4$2.3MEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$84,226,899

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Therini Bio's Form D filed Sep 8, 2025.

LS
DB
MR
Michael Ross
Director
LB
TN
Tara Nickerson
Executive officer and director

Earlier filings also listed Tracy Saxton (director, last listed May 2020), Jeffrey Stavenhagen, Ph.D. (executive officer, last listed May 2020) and Aikaterini Akasoglou (director, last listed May 2020).

Sources

  1. SECTherini Bio, Inc. Form D, filed Apr 14, 2023
  2. SECTherini Bio, Inc. Form D, filed May 17, 2019
  3. SECTherini Bio, Inc. filing history